Telecom Healthcare Sector

Kiora Pharmaceuticals

Market Cap: US$9.5m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

Neuphoria Therapeutics

Market Cap: US$9.5m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Co-Diagnostics

Market Cap: US$9.5m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Biomerica

Market Cap: US$9.3m

A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.

Universal Biosensors

Market Cap: AU$14.3m

Through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.

Streamline Health Solutions

Market Cap: US$9.1m

Provides health information technology solutions and associated services for hospitals and health systems in North America.

Acurx Pharmaceuticals

Market Cap: US$9.1m

A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.

Crigen Resources

Market Cap: AU$13.5m

Operates as a health and wellness company in Australia.

Incanthera

Market Cap: UK£6.7m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Tenon Medical

Market Cap: US$8.9m

A medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.

Intelligent Bio Solutions

Market Cap: US$8.8m

A medical technology company, developing rapid, non-invasive testing, and screening solutions.

BetterLife Pharma

Market Cap: US$8.8m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Scientific Industries

Market Cap: US$8.8m

Engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally.

Talphera

Market Cap: US$8.8m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Cloud DX

Market Cap: CA$12.1m

Operates as a remote patient monitoring company in Canada and the United States.

Cizzle Biotechnology Holdings

Market Cap: UK£6.5m

Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.

Phio Pharmaceuticals

Market Cap: US$8.7m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

IR-Med

Market Cap: US$8.6m

A medical device company, engages in the development of non-invasive devices for various medical indications.

BioXcel Therapeutics

Market Cap: US$8.6m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

UMC

Market Cap: US$8.6m

Provides medical insurance claims coding and processing, electronic medical records storage, chargemaster review, pricing comparison, and accounts receivable management services to healthcare providers.

Xcelerate

Market Cap: US$8.6m

Acquires engineering/patents and applies to early-stage medical technology companies.

Oxford BioDynamics

Market Cap: UK£6.4m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Aethlon Medical

Market Cap: US$8.5m

A medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.

BioVaxys Technology

Market Cap: CA$11.7m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Surgical Innovations Group

Market Cap: UK£6.3m

Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.

Ekso Bionics Holdings

Market Cap: US$8.4m

Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Inspire Veterinary Partners

Market Cap: US$8.4m

Owns and operates veterinary hospitals in the United States.

Cardio Diagnostics Holdings

Market Cap: US$8.3m

Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

AccuStem Sciences

Market Cap: US$8.2m

A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.

Rafarma Pharmaceuticals

Market Cap: US$8.2m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

MyHealthChecked

Market Cap: UK£6.1m

Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

Resverlogix

Market Cap: CA$11.4m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Ainos

Market Cap: US$8.2m

A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine.

Cambridge Nutritional Sciences

Market Cap: UK£6.1m

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East.

Feedback

Market Cap: UK£6.0m

A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging.

Althea Group Holdings

Market Cap: AU$12.5m

Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.